 This review provides a detailed analysis of synthetic routes towards commercial drug compounds containing five-membered heterocycles, specifically focusing on the assembly of their heterocyclic core, using examples from the top 200 best-selling drugs of recent years. This article was authored by Marcus Bauman, Ian R. Baxendale, Stephen V. Lay, and others.